Cargando…
EPA-Enriched Phospholipids Alleviate Renal Interstitial Fibrosis in Spontaneously Hypertensive Rats by Regulating TGF-β Signaling Pathways
Hypertensive nephropathy is a chronic kidney disease caused by hypertension. Eicosapentaenoic acid (EPA) has been reported to possess an antihypertensive effect, and our previous study suggested that EPA-enriched phospholipid (EPA-PL) had more significant bioactivities compared with traditional EPA....
Autores principales: | Shi, Hao-Hao, Zhang, Ling-Yu, Chen, Li-Pin, Yang, Jin-Yue, Wang, Cheng-Cheng, Xue, Chang-Hu, Wang, Yu-Ming, Zhang, Tian-Tian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879699/ https://www.ncbi.nlm.nih.gov/pubmed/35200681 http://dx.doi.org/10.3390/md20020152 |
Ejemplares similares
-
The rapid effects of eicosapentaenoic acid (EPA) enriched phospholipids on alleviating exercise fatigue in mice
por: Wang, Cheng-Cheng, et al.
Publicado: (2019) -
Study on the effects of the different polar group of EPA-enriched phospholipids on the proliferation and apoptosis in 95D cells
por: Guo, Yao, et al.
Publicado: (2021) -
A Comparative Study about the Neuroprotective Effects of DHA-Enriched Phosphatidylserine and EPA-Enriched Phosphatidylserine against Oxidative Damage in Primary Hippocampal Neurons
por: Wang, Yi-Wen, et al.
Publicado: (2023) -
Ruxolitinib Alleviates Renal Interstitial Fibrosis in UUO Mice
por: Bai, Yu, et al.
Publicado: (2020) -
Multiple Mechanisms are Involved in Salt-Sensitive Hypertension-Induced Renal Injury and Interstitial Fibrosis
por: Wei, Shi-Yao, et al.
Publicado: (2017)